Your browser doesn't support javascript.
loading
Inferior cure rate in pilot study of 4-week glecaprevir/pibrentasvir treatment with or without ribavirin of chronic hepatitis C.
Madsen, Lone W; Christensen, Peer B; Fahnøe, Ulrik; Pedersen, Martin S; Bukh, Jens; Øvrehus, Anne.
Affiliation
  • Madsen LW; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Christensen PB; OPEN, Odense Patient data Explorative Network, Odense University Hospital, Odense, Denmark.
  • Fahnøe U; Clinical Institute, University of Southern Denmark, Odense, Denmark.
  • Pedersen MS; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Bukh J; OPEN, Odense Patient data Explorative Network, Odense University Hospital, Odense, Denmark.
  • Øvrehus A; Clinical Institute, University of Southern Denmark, Odense, Denmark.
Liver Int ; 41(11): 2601-2610, 2021 11.
Article in En | MEDLINE | ID: mdl-34154034
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribavirin / Hepatitis C, Chronic Type of study: Clinical_trials Limits: Humans Language: En Journal: Liver Int Journal subject: GASTROENTEROLOGIA Year: 2021 Document type: Article Affiliation country: Dinamarca Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribavirin / Hepatitis C, Chronic Type of study: Clinical_trials Limits: Humans Language: En Journal: Liver Int Journal subject: GASTROENTEROLOGIA Year: 2021 Document type: Article Affiliation country: Dinamarca Country of publication: Estados Unidos